The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
Despite the diverse nature of obesity, there is compelling genetic, clinical, and experimental evidence that endorses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback